Glenview Trust Co Takes $675,000 Position in Ventas, Inc. $VTR

Glenview Trust Co purchased a new position in shares of Ventas, Inc. (NYSE:VTR) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 7,601 shares of the real estate investment trust’s stock, valued at approximately $675,000.

Several other large investors have also made changes to their positions in the company. Dynamic Wealth Strategies LLC acquired a new position in Ventas during the first quarter valued at approximately $25,000. Silvant Capital Management LLC acquired a new stake in shares of Ventas in the 2nd quarter valued at $28,000. Meeder Asset Management Inc. bought a new position in shares of Ventas in the 2nd quarter valued at $30,000. Wiser Advisor Group LLC bought a new position in shares of Ventas in the 3rd quarter valued at $27,000. Finally, IFC & Insurance Marketing Inc. acquired a new position in shares of Ventas during the 4th quarter worth $30,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insiders Place Their Bets

In other news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.53% of the company’s stock.

Ventas Stock Down 1.2%

Shares of NYSE VTR opened at $91.78 on Friday. The firm has a market cap of $47.08 billion, a PE ratio of 169.96, a P/E/G ratio of 2.14 and a beta of 0.69. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60. The company’s fifty day simple moving average is $92.42 and its 200 day simple moving average is $87.57. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $0.87 earnings per share. The business’s revenue was up 21.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

VTR has been the topic of several research analyst reports. Cantor Fitzgerald raised their price objective on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Mizuho raised their price target on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. BMO Capital Markets lifted their price target on shares of Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a report on Tuesday, August 11th. UBS Group upped their price objective on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price objective on shares of Ventas in a research note on Tuesday, May 19th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.